Fine Foods & Pharmaceuticals N.T.M. (BIT: FF) net income
Fine Foods & Pharmaceuticals N.T.M. reported a net profit of €10.1m for fiscal 2025, 23.8% more than in fiscal 2024 (€8.2m). Its net margin was 4.0%. Earnings per share were €0.41.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | €10.1m | +23.8% | 4.0% | €0.41 |
| 2024 | €8.2m | — | 3.3% | €0.32 |
| 2023 | −€3.5m | — | −1.4% | −€0.14 |
| 2022 | −€9.5m | — | −4.6% | −€0.37 |
| 2021 | −€1.4m | — | −0.7% | −€0.06 |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of euros, except per-share amounts.
Questions about the net income of Fine Foods & Pharmaceuticals N.T.M.
- How much did Fine Foods & Pharmaceuticals N.T.M. earn in fiscal 2025?
- Fine Foods & Pharmaceuticals N.T.M. reported a net profit of €10.1m for fiscal 2025. In fiscal 2024 it reported a net profit of €8.2m.
- What are the earnings per share of Fine Foods & Pharmaceuticals N.T.M.?
- They were €0.41 in fiscal 2025, compared with €0.32 in fiscal 2024.
- What is the net margin of Fine Foods & Pharmaceuticals N.T.M.?
- In fiscal 2025 its net profit was 4.0% of its revenue.
- What was the most profitable year for Fine Foods & Pharmaceuticals N.T.M.?
- Of its last 5 fiscal years, fiscal 2025, with €10.1m.
- Where do the figures for Fine Foods & Pharmaceuticals N.T.M. come from?
- From the report Fine Foods & Pharmaceuticals N.T.M. files every year in the European single electronic format (ESEF), the one it files with the regulator of its home market. Each fiscal year links to its filing.
Where each figure comes from
From the annual report Fine Foods & Pharmaceuticals N.T.M. files every year in the European single electronic format (ESEF). The filing for each fiscal year: 2025 · 2024 · 2023 · 2022. More on Fine Foods & Pharmaceuticals N.T.M.: the Fine Foods & Pharmaceuticals N.T.M. page · annual accounts · revenue · dividends paid.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.